Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Amb a 1 is the major allergen found in the pollen of short ragweed (*Ambrosia artemisiifolia*). It is a pectate lyase enzyme and a primary cause of ragweed pollen allergy, responsible for over 90% of IgE-mediated responses in sensitized individuals. It is a key marker for diagnosing ragweed pollen sensitization and a target for allergen-specific immunotherapy.
Target of allergen-specific immunotherapy (e.g., allergy shots) aims to desensitize the immune system to Amb a 1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Amb a 1 Protein (Amb a 1).